New cancer vaccine could change how doctors fight deadly melanoma, expert says
Dr. Murad Alam, chief of dermatology at Northwestern Medicine in Chicago, shares the significance of Merck and Moderna's 'very exciting' phase 3 trial results for a personalized melanoma vaccine.
